Drug Approval | January 12, 2026
FDA rejects Vanda’s jet lag drug in current form
Vanda strongly disputes the FDA’s reasoning
Vanda strongly disputes the FDA’s reasoning
The clearance marks a major step in Diabeloop’s ambition to become a central partner for insulin pump manufacturers and expand access to automated insulin delivery in the US market
The decision follows an interim analysis conducted when roughly half of the patients had completed their Day 84 visit
Collaboration funds participating biotechs to access Lilly predictive models through the Revvity Signals Xynthetica offering
Tiger Shroff fronts ‘Fit Raho, Hit Raho’ campaign
SLE remains a life-threatening autoimmune disease, with patients facing an elevated risk of early mortality and long-term organ damage
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
He noted the enduring relevance of Siddha medicine as “a comprehensive, preventive and sustainable healthcare system in the contemporary world
The funding will accelerate Sinopia’s data-driven drug discovery efforts
Intas becomes the first and only company in India to offer IVF and gynecology therapies with needle-free injections
Subscribe To Our Newsletter & Stay Updated
